Back to Search Start Over

DC therapy? Let the natural killer answer

Authors :
Sherif S. Farag
Source :
Blood. 106:1892-1892
Publication Year :
2005
Publisher :
American Society of Hematology, 2005.

Abstract

Comment on Fauriat et al, page [2186][1] Natural killer cells from the majority of AML patients show defective killing of immature dendritic cells due to low expression of the natural cytotoxicity receptor NKp30. Defective killing of immature DCs leads to the emergence of tolerogenic T cells and

Details

ISSN :
15280020 and 00064971
Volume :
106
Database :
OpenAIRE
Journal :
Blood
Accession number :
edsair.doi...........ad9a82d7b0aa5101704d9e8f5eb94d2e